Business ❯Pharmaceuticals

Investment

Manufacturing Private Equity Public Investment Government Funding International Business Dublin Development Research and Development Clinical Trials

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

AstraZeneca Cancels £450m UK Vaccine Plant Investment